Agendia appointed last week six new members to its clinical and scientific advisory board. The advisors will review early research programs and provide academic and clinical evaluations. The advisory board will be chaired by Piet Borst, emeritus director of the Netherlands Cancer Institute.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.